Dr. David Wilpula is a pharmacist who is specialized in Pharmacotherapy in Dearborn, Michigan. Patients can reach him at 18101 Oakwood Blvd, Dearborn or contact him on 313-996-7293. Active license number of Dr. David Wilpula is 5302034721 for Pharmacotherapy in Michigan. Dr. David Wilpula is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. David Wilpula speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. David Wilpula are as mentioned below.
NPI Number:
1235331653
NPI Enumeration Date:
05 Jun, 2007
NPI Last Update On:
06 Aug, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. David Wilpula are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
5302034721
Michigan
Primary
Pharmacotherapy
RP437847
Pennsylvania
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
30254 Westgate Rd, Farmington Hills, Michigan
Zip:
48334-2347
Phone Number:
248-539-0524
Fax Number:
313-593-8823
Patients can reach Dr. David Wilpula at 18101 Oakwood Blvd, Dearborn, Michigan or can call on phone at 313-996-7293.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.